SANKET VYAS: Open Payments
NPI 1932263613 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 31 payments from 7 companies in 2025. Trend: 2023 $656 · 2024 $1,229 · 2025 $951
Food & beverage: $751Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 13 | $406 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| E.R. Squibb & Sons, L.L.C. | 8 | $149 |
| Tempus AI, Inc | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: ARISTADA, SPRAVATO, COBENFY, LYBALVI, TEMPUS PIXEL, ABILIFY ASIMTUFII, UZEDY, INGREZZA.
Industry payments across LA — which companies pay providers there.
